EUVIMEDEUVIMED entdecken
Vergleichsstudie

Comparison of CRISPR-Cas-Based Knockdown of Endogenous mRNA in Sensory Neurons

Andrea Meulenberg, Macarena Pavez, Emma K Gowing, David Mayo-Muñoz iD, Nils Birkholz, Graceallah Suhono, Peter C Fineran, Robert D Fagerlund, Laura F Gumy iD

The CRISPR Journal · 01.12.2026 · 9 (5-6) · 285-296

DOI: 10.1177/25731599261489437 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift The CRISPR Journal, online erschienen am 23.09.2026. Verfasst von Andrea Meulenberg und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anatomy, University of Otago, Dunedin, New Zealand. Hauptthemen laut MEDLINE: CRISPR-Cas Systems, Gene Knockdown Techniques, RNA, Messenger, Sensory Receptor Cells. Die Arbeit nennt 39 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ribonucleic acid (RNA)–targeting clustered regularly interspaced short palindromic repeats–CRISPR-associated (CRISPR-Cas) systems enable modulation of gene expression without permanent genome modification, making them useful for sensitive cell types such as neurons. While CRISPR-Cas technologies have been most extensively applied and validated in primary hippocampal and cortical neurons, their use in sensory neurons remains largely unexplored. Sensory neurons are an established cellular model for studying axon growth and regeneration, pain mechanisms, sensory transduction, and neuron–environment interactions. Here, we evaluated the performance of compact RNA-targeting CRISPR-Cas effectors Cas7-11S, hfCas13X, and hfCas13d in primary rat sensory neurons in culture. Using an endogenous mRNA as the target, we compared knockdown efficiency and assessed the effects of CRISPR-Cas expression on neuronal health. The systems showed distinct differences in performance, with Cas7-11S inducing toxicity, hfCas13X showing minimal knockdown, and hfCas13d providing robust gene silencing with minimal adverse effects on neuronal health. These findings identify hfCas13d as the most effective and well-tolerated RNA-targeting CRISPR-Cas tool for sensory neurons and provide important insight into its suitability for neuroscience research and potential therapeutic applications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CRISPR-Cas SystemsGene Knockdown TechniquesRNA, MessengerSensory Receptor CellsAnimalsRatsCells, CulturedClustered Regularly Interspaced Short Palindromic RepeatsGene Silencing

Substanzen

RNA, Messenger

Autor:innen und Institutionen

  • Department of Anatomy, University of Otago, Dunedin, New Zealand.
  • Department of Microbiology and Immunology, University of Otago, Dunedin, New Zealand.
  • Maurice Wilkins Centre for Molecular Biodiscovery, University of Otago, Dunedin, New Zealand.
  • Genetics Otago, University of Otago, Dunedin, New Zealand.
  • Bioprotection Aotearoa, University of Otago, Dunedin, New Zealand.

ORCID-Profile: David Mayo-Muñoz, Laura F Gumy

Zitieren

APA

Meulenberg, A., Pavez, M., Gowing, E. K., Mayo-Muñoz, D., Birkholz, N., Suhono, G., Fineran, P. C., Fagerlund, R. D., & Gumy, L. F. (2026). Comparison of CRISPR-Cas-Based Knockdown of Endogenous mRNA in Sensory Neurons. The CRISPR Journal, 9(5-6), 285-296. https://doi.org/10.1177/25731599261489437

Vancouver

Meulenberg A, Pavez M, Gowing EK, Mayo-Muñoz D, Birkholz N, Suhono G, et al. Comparison of CRISPR-Cas-Based Knockdown of Endogenous mRNA in Sensory Neurons. The CRISPR Journal. 2026;9(5-6):285-296. doi:10.1177/25731599261489437

BibTeX
@article{Meulenberg2026,
  author = {Meulenberg, Andrea and Pavez, Macarena and Gowing, Emma K and Mayo-Muñoz, David and Birkholz, Nils and Suhono, Graceallah and Fineran, Peter C and Fagerlund, Robert D and Gumy, Laura F},
  title = {Comparison of CRISPR-Cas-Based Knockdown of Endogenous mRNA in Sensory Neurons},
  journal = {The CRISPR Journal},
  year = {2026},
  volume = {9},
  number = {5-6},
  pages = {285--296},
  doi = {10.1177/25731599261489437}
}
Kostenlos starten →